Fresenius Medical Care AG & Co. KGaA
FMS
Cena:
$ 21.64
+0.01 (0.05%)
Valuace
76
Růst
38
Zdraví
66
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
FRESENIUS MEDICAL CARE ACCELERATES THE SECOND TRANCHE OF ITS EUR 1 BILLION SHARE BUYBACK PROGRAM WITH AROUND EUR 415 MILLION REPURCHASE PLANNED
09-01-2026
THE SECOND TRANCHE OF THE SHARE BUYBACK IS EXPECTED TO BE EXECUTED BY MAY 8, 2026 THE SHARE BUYBACK ...
Více zde
FRESENIUS MEDICAL CARE APPOINTS CHARLES HUGH-JONES AS GLOBAL CHIEF MEDICAL OFFICER AND MEMBER OF THE MANAGEMENT BOARD
10-12-2025
EFFECTIVE JANUARY 1, 2026, CHARLES HUGH-JONES WILL JOIN THE MANAGEMENT BOARD AS GLOBAL CHIEF MEDICAL...
Více zde
FRESENIUS MEDICAL CARE FURTHER ACCELERATES ORGANIC REVENUE DEVELOPMENT AND ACHIEVES AN INFLECTION IN EARNINGS GROWTH, DELIVERING 28% OPERATING INCOME GROWTH IN THE THIRD QUARTER OF 2025
04-11-2025
STRONG ORGANIC REVENUE GROWTH1 OF 10% DRIVEN BY ALL OPERATING SEGMENTS POSITIVE U.S. SAME MARKET TRE...
Více zde
FRESENIUS MEDICAL CARE HIGHLIGHTS REAL-WORLD ADVANCES IN HEMODIAFILTRATION AND AI AT ASN KIDNEY WEEK 2025
30-10-2025
FRESENIUS MEDICAL CARE RESEARCHERS WILL PRESENT MULTIPLE ABSTRACTS THAT DEMONSTRATE PROVEN, REAL-WOR...
Více zde
FRESENIUS MEDICAL CARE APPOINTS JOSEPH TURK AS NEW MANAGEMENT BOARD MEMBER FOR CARE ENABLEMENT
01-10-2025
EFFECTIVE JANUARY 1, 2026, JOSEPH TURK WILL JOIN THE MANAGEMENT BOARD AS CHIEF EXECUTIVE OFFICER OF ...
Více zde
FRESENIUS MEDICAL CARE ADVANCES ITS FME REIGNITE STRATEGY BY INCREASING OWNERSHIP IN ITS VALUE-BASED CARE ASSET AND APPOINTING A NEW LEADER FOR THE OPERATING SEGMENT
18-09-2025
FRESENIUS MEDICAL CARE INVESTS EUR 312 MILLION AND SUCCESSFULLY CLOSES A SHARE PURCHASE AGREEMENT WI...
Více zde
FRESENIUS MEDICAL CARE ANNOUNCES FIRST TRANCHE OF ITS SHARE BUYBACK PROGRAM OF UP TO EUR 600 MILLION AS PART OF ITS NEW CAPITAL ALLOCATION FRAMEWORK
11-08-2025
TOTAL VOLUME OF THE INITIAL SHARE BUYBACK IS UP TO EUR 1 BILLION OVER TWO YEARS SHARE BUYBACK TO TAK...
Více zde
FOCUS GRAPHITE ADVANCED MATERIALS ANNOUNCES CLOSING OF C$891,000 NON-BROKERED PRIVATE PLACEMENT
08-08-2025
OTTAWA, ONTARIO--(NEWSFILE CORP. - AUGUST 8, 2025) - FOCUS GRAPHITE ADVANCED MATERIALS INC. (TSXV: F...
Více zde
SILICON MOTION SHOWCASES MONTITAN™ SM8366 IN CORE TO EDGE AI SERVER APPLICATIONS AT FMS 2025
05-08-2025
COMPANY ALSO DEMONSTRATES FULL SPECTRUM OF AI STORAGE SOLUTIONS FOR PCS, GAMING, EDGE, ROBOTICS, AND...
Více zde
FRESENIUS MEDICAL CARE DELIVERS STRONG ORGANIC REVENUE GROWTH AND DOUBLE-DIGIT OPERATING INCOME GROWTH IN THE SECOND QUARTER OF 2025
05-08-2025
STRONG ORGANIC REVENUE GROWTH1 OF 7% DRIVEN BY ALL OPERATING SEGMENTS STABLE U.S. SAME MARKET TREATM...
Více zde
$6.3 TRILLION OUTPATIENT CLINICS MARKETS, 2021-2024 & 2025-2029 | PROFILES OF LEADING PLAYERS - JOHNS HOPKINS MEDICINE, MAYO CLINIC, MD ANDERSON CANCER CENTER, APOLLO HOSPITAL, AND FRESENIUS MEDICAL
18-07-2025
EXPLORE THE LATEST REPORT ON THE GLOBAL OUTPATIENT CLINICS MARKET, ANALYZING TRENDS, REVENUE, AND FO...
Více zde
FRESENIUS MEDICAL CARE COLLABORATES WITH COORDINATION OF NATIONAL INSTITUTES OF HEALTH AND SPECIALTY HOSPITAL TO EXTEND ACCESS TO INNOVATIVE DIALYSIS THERAPY IN MEXICO
03-07-2025
HIGH-VOLUME HEMODIAFILTRATION IS USED FOR THE FIRST TIME IN SEVEN OUT OF 10 CCINSHAE CENTERS IN MEXI...
Více zde
FRESENIUS MEDICAL CARE LAUNCHES ITS STRATEGY FME REIGNITE WITH INCREASED PROFITABILITY ASPIRATIONS, AND A NEW CAPITAL ALLOCATION FRAMEWORK TO FURTHER ENHANCE VALUE CREATION
17-06-2025
FME REIGNITE SETS THE AMBITION TO LEAD KIDNEY CARE THROUGH EXCEPTIONAL PATIENT CARE AND INNOVATION T...
Více zde
FOCUS GRAPHITE ACHIEVES 5N PURITY FROM LAC KNIFE GRAPHITE, REFINED TO NUCLEAR-GRADE PURITY LEVELS IN AETC TESTING
12-06-2025
THERMAL PURIFICATION RUN ON LAC KNIFE CONCENTRATE MATERIAL PRODUCED AND CHARACTERIZED BY AETC HAS RE...
Více zde
FRESENIUS MEDICAL CARE BEGINS BROADER U.S. COMMERCIALIZATION OF 5008X™ CARESYSTEM, ACHIEVES KEY MILESTONES IN EFFORTS TO INTRODUCE HIGH-VOLUME HEMODIAFILTRATION DIALYSIS THERAPY TO INDIVIDUALS WITH KIDNEY DISEASE IN THE U.S.
04-06-2025
UPDATED 5008X CARESYSTEM WITH ADDITIONAL FEATURES RECEIVES FDA 510(K) CLEARANCE COMPANY ANNOUNCES F...
Více zde
FRESENIUS MEDICAL CARE PRESENTS ITS NEW RESEARCH AND INNOVATION FOR KIDNEY CARE AT EUROPEAN RENAL ASSOCIATION CONGRESS 2025
30-05-2025
KEY ABSTRACT PRESENTATIONS SHOWCASE SIGNIFICANT ADVANCEMENTS IN CLINICAL CARE, ARTIFICIAL INTELLIGEN...
Více zde
FRESENIUS MEDICAL CARE ANNUAL GENERAL MEETING: STRONG PERFORMANCE AGAINST ITS STRATEGIC PLAN RESULTS IN HIGHEST DIVIDEND PER SHARE IN ITS HISTORY
22-05-2025
SHAREHOLDERS APPROVED THE PROPOSED DIVIDEND OF 1.44 EURO PER SHARE, REPRESENTING A 21 PERCENT INCREA...
Více zde
FOCUS GRAPHITE ANNOUNCES THE GRANT OF INCENTIVE STOCK OPTIONS TO ITS OFFICERS AND CONSULTANTS
14-05-2025
OTTAWA, ON / ACCESS NEWSWIRE / MAY 14, 2025 / FOCUS GRAPHITE ADVANCED MATERIALS INC. (TSXV:FMS)(OTCQ...
Více zde
FRESENIUS MEDICAL CARE STARTS 2025 WITH STRONG ORGANIC REVENUE AND INCOME GROWTH
06-05-2025
STRONG ORGANIC REVENUE GROWTH1 OF 5% DRIVEN BY CARE ENABLEMENT AND CARE DELIVERY STABLE U.S. SAME MA...
Více zde
AVYANCE HELPS DRIVE SUCCESSFUL ADOPTION OF ORACLE CLOUD FINANCIAL MANAGEMENT SYSTEM (FMS) AT NATIONAL GALLERY OF ART
16-04-2025
WASHINGTON--(BUSINESS WIRE)-- #ARTMEETSTECH--AVYANCE HELPS LAUNCH FIRST ORACLE CLOUD FEDERAL FINANCI...
Více zde
FRESENIUS MEDICAL CARE PUBLISHES ITS JOINT ANNUAL REPORT AND SUSTAINABILITY STATEMENT FOR 2024: BUILDING THE MOMENTUM
13-03-2025
IN 2024, THE OPERATING MODEL TO DELIVER THE HIGHEST QUALITY OF PATIENT CARE WAS FURTHER OPTIMIZED BY...
Více zde
FRESENIUS MEDICAL CARE DELIVERS 18% EARNINGS GROWTH IN 2024 AND CONTINUES THE ACCELERATION MOMENTUM INTO 2025
25-02-2025
ORGANIC REVENUE GROWTH1 OF 4% DRIVEN BY CARE ENABLEMENT AND CARE DELIVERY UNDERLYING U.S. SAME MARK...
Více zde
FRESENIUS MEDICAL CARE ANNOUNCES DIVESTMENT OF SELECT LABORATORY ASSETS TO QUEST DIAGNOSTICS
24-02-2025
QUEST TO PROVIDE COMPREHENSIVE DIALYSIS-RELATED LABORATORY AND WATER TESTING SERVICES TO FRESENIUS ...
Více zde
FOCUS GRAPHITE ADVANCED MATERIALS PROVIDES UPDATE ON PATENT PENDING SILICON-ENHANCED SPHEROIDIZED GRAPHITE TECHNOLOGY FOR BATTERY ANODES
10-02-2025
THE COMPANY'S PATENT PENDING SILICON-ENHANCED SPHEROIDIZED GRAPHITE TECHNOLOGY REPRESENTS A BREAKTHR...
Více zde
FRESENIUS MEDICAL CARE LISTED IN THE DOW JONES SUSTAINABILITY WORLD INDEX AND FOR THE 15TH TIME IN THE DOW JONES SUSTAINABILITY EUROPE INDEX
23-12-2024
RANKING PUTS FRESENIUS MEDICAL CARE AMONG THE BEST-IN-CLASS SUSTAINABILITY PERFORMERS IN THE WORLD A...
Více zde
FRESENIUS MEDICAL CARE RETURNS TO DAX 40 INDEX
20-12-2024
BAD HOMBURG, GERMANY , DEC. 20, 2024 /PRNEWSWIRE/ -- FRESENIUS MEDICAL CARE (FME), THE WORLD'S LEADI...
Více zde
FRESENIUS MEDICAL CARE REPORTS STRONG OPERATING INCOME MARGIN GROWTH IN THE THIRD QUARTER OF 2024
05-11-2024
ORGANIC REVENUE GROWTH OF +2% SUPPORTED BY CARE ENABLEMENT AND CARE DELIVERY UNDERLYING U.S. DIALYSI...
Více zde
FRESENIUS MEDICAL CARE SHOWCASES RESEARCH AND INNOVATIONS IN KIDNEY CARE AT AMERICAN SOCIETY OF NEPHROLOGY (ASN) KIDNEY WEEK 2024
21-10-2024
A DEDICATED SESSION WILL HIGHLIGHT NEW ADVANCEMENTS IN HEMODIAFILTRATION THERAPY SHOWCASING ITS POT...
Více zde
FRESENIUS MEDICAL CARE GROWS NUMBER OF U.S. PATIENTS USING COMPANY'S HOME HEMODIALYSIS MACHINES, LAUNCHES NXSTAGE® VERSI®HD WITH GUIDEME SOFTWARE
04-09-2024
FRESENIUS MEDICAL CARE ACHIEVES GROWTH MILESTONE OF MORE THAN 14,000 U.S.-BASED PATIENTS USING THE C...
Více zde
MARVELL TO SHOWCASE LATEST CLOUD STORAGE AND CXL MEMORY TECHNOLOGIES AT FMS 2024
07-08-2024
AWARDED MOST INNOVATIVE SUSTAINABILITY TECHNOLOGY FOR MARVELL® STRUCTERA™ X CXL MEMORY-EXPANSION ...
Více zde
Dokumenty nejsou k dispozici
